Image

A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET

Researching the Combination of Investigational Medications for Pancreatic Neuroendocrine Tumors

Recruiting
18-80 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates pancreatic neuroendocrine tumors. These tumors are gaining attention due to their increasing incidence and limited effective treatment options.

The study evaluates the combination of investigational medications to see if they can improve treatment outcomes. It looks into how these medications might work together to address issues like drug resistance.

  • Who can participate: Adults aged 18 to 80 with pancreatic neuroendocrine tumors that have progressed after treatments like SSA or chemotherapy can participate, provided they have measurable lesions and adequate organ function.
  • Study details: Participants will take investigational medications that may include a placebo. A placebo is an inactive substance that looks like the investigational medicine but does not contain any medicine.
Print
Study details
    Pancreatic Neuroendocrine Neoplasm
    Sorafenib
    Gefitinib

NCT06592989

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.